Bill Text: NH HB190 | 2015 | Regular Session | Chaptered
Bill Title: Establishing a statutory commission to study the standards for collaborative pharmacy practice.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Passed) 2015-07-07 - Signed by the Governor on 7/6/2015; Chapter 190; Section 3 Effective 11/2/2015, Remaining Effective 7/6/2015 [HB190 Detail]
Download: New_Hampshire-2015-HB190-Chaptered.html
CHAPTER 190
HB 190 – FINAL VERSION
11Feb2015… 0164h
04/30/2015 1337s
11June2015… 2103EBA
2015 SESSION
10/04
HOUSE BILL 190
AN ACT establishing a statutory commission to study the standards for collaborative pharmacy practice.
SPONSORS: Rep. MacKay, Merr 14; Rep. White, Graf 13; Rep. Schuett, Merr 20
COMMITTEE: Health, Human Services and Elderly Affairs
This bill establishes a statutory commission to study the standards for collaborative pharmacy practice.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
11Feb2015… 0164h
04/30/2015 1337s
11June2015… 2103EBA
2015 SESSION
15-0420
10/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Fifteen
AN ACT establishing a statutory commission to study the standards for collaborative pharmacy practice.
Be it Enacted by the Senate and House of Representatives in General Court convened:
190:1 Purpose. Today more and more Americans are suffering from chronic diseases, taking multiple medications, and struggling with higher and higher healthcare costs. The establishment of a commission to study standards for collaborative pharmacy practice is an important first step for the state of New Hampshire to move towards fully utilizing pharmacists to improve health outcomes and to lower healthcare costs. Pharmacists represent the third largest profession and consistently rank among the most accessible and trusted of healthcare professions. It is imperative the state of New Hampshire take this step in expanding access to team-based care and ensuring that pharmacists are allowed to be on the team when a physician deems it necessary.
190:2 New Section; Collaborative Pharmacy Practice; Commission Established. Amend RSA 318 by inserting after section 16-b the following new section:
318:16-c Commission to Study the Standards for Collaborative Pharmacy Practice. There is established a commission to study the standards for collaborative pharmacy practice.
I. The members of the commission shall be as follows:
(a) One member of the senate, appointed by the president of the senate.
(b) Three members of the house of representatives, appointed by the speaker of the house of representatives, 2 of whom shall be members of the health, human services and elderly affairs committee and one of whom shall be a member of the executive departments and administration committee.
(c) A representative of the New Hampshire Society of Health-System Pharmacists, appointed by the society.
(d) A representative of the New Hampshire Pharmacists Association, appointed by the association.
(e) A representative of the New Hampshire board of pharmacy, appointed by the board.
(f) A representative from the Coalition of New Hampshire Chain Drug Stores, appointed by the coalition.
(g) A representative from the New Hampshire Independent Pharmacy Association, appointed by the association.
(h) A provider from a healthcare facility that is currently participating in a collaborative practice agreement approved by the board of pharmacy, appointed by the board.
(i) A pharmacist from a healthcare facility that is currently participating in a collaborative practice agreement approved by the board of pharmacy, appointed by the board.
(j) A representative from the New Hampshire Hospital Association, appointed by the association.
(k) A representative of the New Hampshire Medical Society, appointed by the society.
(l) A representative of the board of nursing, appointed by the board.
(m) A representative of the New Hampshire Nurse Practitioners Association, appointed by the association.
(n) A member who is a family physician, appointed by the board of medicine.
(o) A member who is an internist, appointed by the board of medicine.
II. Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.
III. The commission’s study shall include, but not be limited to:
(a) Reviewing RSA 318:16-a and discussing areas where it is working effectively and
where there are areas for improvement in the current framework of regulatory oversight;
(b) Studying the national standards for best practice of collaborative practice;
(c) Defining the appropriate training required for a pharmacist to engage in different scopes of practice;
(d) Discussing how to expand access to collaborative practice pharmacy services to New Hampshire citizens in order to provide greater access to cost-effective care;
(e) Defining collaborative pharmacy practice environments to ensure safety;
(f) Identifying recommended solutions, both legislative and non-legislative; and
(g) Reviewing any other matter the committee deems relevant to its objective.
IV. The members of the commission shall elect a chairperson from among the members. The first meeting of the commission shall be called by the first-named house member. The first meeting of the commission shall be held within 30 days of the effective date of this section. Five members of the commission shall constitute a quorum.
V. The commission shall report its findings and any recommendations for proposed legislation to the speaker of the house of representatives, the president of the senate, the house clerk, the senate clerk, the governor, and the state library on or before November 1, 2015.
190:3 Repeal. RSA 318:16-c, relative to the commission to study the standards for collaborative pharmacy practice, is repealed.
190:4 Effective Date.
I. Section 3 of this act shall take effect November 2, 2015.
II. The remainder of this act shall take effect upon its passage.
Approved: July 6, 2015
Effective Date: I. Section 3 shall take effect November 2, 2015.
II. Remainder shall take effect July 6, 2015.
